Literature DB >> 28092083

Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.

Federica Bono1, Paola Savoia2, Adele Guglielmi2, Massimo Gennarelli3,4, Giovanna Piovani3, Sandra Sigala2, Damiana Leo5, Stefano Espinoza5, Raul R Gainetdinov5,6,7, Paola Devoto8, PierFranco Spano2,9, Cristina Missale2,9, Chiara Fiorentini2.   

Abstract

The role of dopamine D2 and D3 receptors (D2R/D3R), located on midbrain dopaminergic (DA) neurons, in the regulation of DA synthesis and release and in DA neuron homeostasis has been extensively investigated in rodent animal models. By contrast, the properties of D2R/D3R in human DA neurons have not been elucidated yet. On this line, the use of human-induced pluripotent stem cells (hiPSCs) for producing any types of cells has offered the innovative opportunity for investigating the human neuronal phenotypes at the molecular levels. In the present study, hiPSCs generated from human dermal fibroblasts were used to produce midbrain DA (mDA) neurons, expressing the proper set of genes and proteins typical of authentic, terminally differentiated DA neurons. In this model, the expression and the functional properties of the human D2R/D3R were investigated with a combination of biochemical and functional techniques. We observed that in hiPSC-derived mDA neurons, the activation of D2R/D3R promotes the proliferation of neuronal progenitor cells. In addition, we found that D2R/D3R activation inhibits nicotine-stimulated DA release and exerts neurotrophic effects on mDA neurons that likely occur via the activation of PI3K-dependent mechanisms. Furthermore, D2R/D3R stimulation counteracts both the aggregation of alpha-synuclein induced by glucose deprivation and the associated neuronal damage affecting both the soma and the dendrites of mDA neurons. Taken together, these data point to the D2R/D3R-related signaling events as a biochemical pathway crucial for supporting both neuronal development and survival and protection of human DA neurons.

Entities:  

Keywords:  Development; Dopamine D2/D3 receptor; Neurodegeneration; Neuroplasticity; Nicotine; hiPSC

Mesh:

Substances:

Year:  2017        PMID: 28092083     DOI: 10.1007/s12035-016-0376-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  63 in total

Review 1.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

Review 2.  The roles of microtubule-associated proteins in brain morphogenesis: a review.

Authors:  R P Tucker
Journal:  Brain Res Brain Res Rev       Date:  1990 May-Aug

3.  Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.

Authors:  Ginetta Collo; Federica Bono; Laura Cavalleri; Laura Plebani; Stefania Mitola; Emilio Merlo Pich; Mark J Millan; Michele Zoli; Uwe Maskos; Pierfranco Spano; Cristina Missale
Journal:  Mol Pharmacol       Date:  2013-03-29       Impact factor: 4.436

Review 4.  The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

Authors:  P Sokoloff; J Diaz; B Le Foll; O Guillin; L Leriche; E Bezard; C Gross
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-02       Impact factor: 4.388

5.  Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Authors:  Alan L Whone; Ray L Watts; A Jon Stoessl; Margaret Davis; Sven Reske; Claude Nahmias; Anthony E Lang; Olivier Rascol; Maria J Ribeiro; Philippe Remy; Werner H Poewe; Robert A Hauser; David J Brooks
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

6.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

7.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Authors:  Peter Reinhardt; Benjamin Schmid; Lena F Burbulla; David C Schöndorf; Lydia Wagner; Michael Glatza; Susanne Höing; Gunnar Hargus; Susanna A Heck; Ashutosh Dhingra; Guangming Wu; Stephan Müller; Kathrin Brockmann; Torsten Kluba; Martina Maisel; Rejko Krüger; Daniela Berg; Yaroslav Tsytsyura; Cora S Thiel; Olympia-Ekaterini Psathaki; Jürgen Klingauf; Tanja Kuhlmann; Marlene Klewin; Heiko Müller; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease.

Authors:  Howard D Weiss; Laura Marsh
Journal:  Neurol Clin Pract       Date:  2012-12

9.  Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.

Authors:  Kenjiro Ono; Mie Hirohata; Masahito Yamada
Journal:  Exp Neurol       Date:  2007-03-07       Impact factor: 5.330

Review 10.  The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Authors:  Matthew J Benskey; Ruth G Perez; Fredric P Manfredsson
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

View more
  10 in total

Review 1.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

2.  α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability.

Authors:  Abeer Dagra; Douglas R Miller; Min Lin; Adithya Gopinath; Fatemeh Shaerzadeh; Sharonda Harris; Zachary A Sorrentino; Jonatan Fullerton Støier; Sophia Velasco; Janelle Azar; Adetola R Alonge; Joseph J Lebowitz; Brittany Ulm; Mengfei Bu; Carissa A Hansen; Nikhil Urs; Benoit I Giasson; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2021-08-18

3.  Multiple System Atrophy (MSA) and smoking: a meta-analysis and mechanistic insights.

Authors:  Fan-Shuen Tseng; Xiao Deng; Yi-Lin Ong; Hui-Hua Li; Eng-King Tan
Journal:  Aging (Albany NY)       Date:  2020-11-07       Impact factor: 5.682

4.  Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features.

Authors:  Pengfei Yang; William C Knight; Huifangjie Li; Yingqiu Guo; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ann Clin Transl Neurol       Date:  2020-12-21       Impact factor: 4.511

5.  Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.

Authors:  Razan Sheta; Maxime Teixeira; Walid Idi; Marion Pierre; Aurelie de Rus Jacquet; Vincent Emond; Cornelia E Zorca; Benoît Vanderperre; Thomas M Durcan; Edward A Fon; Frédéric Calon; Mohamed Chahine; Abid Oueslati
Journal:  Sci Rep       Date:  2022-10-13       Impact factor: 4.996

6.  Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons.

Authors:  Federica Bono; Chiara Fiorentini
Journal:  Neural Regen Res       Date:  2017-07       Impact factor: 5.135

Review 7.  Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.

Authors:  Francesca Longhena; Gaia Faustini; Maria Grazia Spillantini; Arianna Bellucci
Journal:  Int J Mol Sci       Date:  2019-01-02       Impact factor: 5.923

Review 8.  Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection.

Authors:  Federica Bono; Veronica Mutti; Chiara Fiorentini; Cristina Missale
Journal:  Biomolecules       Date:  2020-07-09

9.  Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes.

Authors:  Alice Filippini; Veronica Mutti; Gaia Faustini; Francesca Longhena; Ileana Ramazzina; Federica Rizzi; Alice Kaganovich; Dorien A Roosen; Natalie Landeck; Megan Duffy; Isabella Tessari; Federica Bono; Chiara Fiorentini; Elisa Greggio; Luigi Bubacco; Arianna Bellucci; Mariacristina Missale; Mark R Cookson; Massimo Gennarelli; Isabella Russo
Journal:  Glia       Date:  2020-10-12       Impact factor: 7.452

10.  Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway.

Authors:  Veronica Mutti; Federica Bono; Zaira Tomasoni; Leonardo Bontempi; Adele Guglielmi; Silvia Bolognin; Jens C Schwamborn; Cristina Missale; Chiara Fiorentini
Journal:  Mol Neurobiol       Date:  2022-01-19       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.